Adverse events60

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

41 to 60 of 60

Type	Event	Organ system	Group	Affected	At risk
other	Nasopharyngitis	Infections and infestations	d-ATS Patch Treated Arm During the Double Blind Phase	3	106
other	Nasopharyngitis	Infections and infestations	Placebo Treated Arm During the Double Blind Phase	2	106
other	Cough	Respiratory, thoracic and mediastinal disorders	All d-ATS Treatment During the Dose-Optimization Phase	28	110
other	Cough	Respiratory, thoracic and mediastinal disorders	d-ATS Patch Treated Arm During the Double Blind Phase	2	106
other	Cough	Respiratory, thoracic and mediastinal disorders	Placebo Treated Arm During the Double Blind Phase	3	106
other	Nasal congestion	Respiratory, thoracic and mediastinal disorders	All d-ATS Treatment During the Dose-Optimization Phase	17	110
other	Nasal congestion	Respiratory, thoracic and mediastinal disorders	d-ATS Patch Treated Arm During the Double Blind Phase	0	106
other	Nasal congestion	Respiratory, thoracic and mediastinal disorders	Placebo Treated Arm During the Double Blind Phase	3	106
other	Abdominal upper pain	Gastrointestinal disorders	All d-ATS Treatment During the Dose-Optimization Phase	16	110
other	Abdominal upper pain	Gastrointestinal disorders	d-ATS Patch Treated Arm During the Double Blind Phase	3	106
other	Abdominal upper pain	Gastrointestinal disorders	Placebo Treated Arm During the Double Blind Phase	1	106
other	Nausea	Gastrointestinal disorders	All d-ATS Treatment During the Dose-Optimization Phase	13	110
other	Nausea	Gastrointestinal disorders	d-ATS Patch Treated Arm During the Double Blind Phase	3	106
other	Nausea	Gastrointestinal disorders	Placebo Treated Arm During the Double Blind Phase	1	106
other	Vomiting	Gastrointestinal disorders	All d-ATS Treatment During the Dose-Optimization Phase	8	110
other	Vomiting	Gastrointestinal disorders	d-ATS Patch Treated Arm During the Double Blind Phase	4	106
other	Vomiting	Gastrointestinal disorders	Placebo Treated Arm During the Double Blind Phase	0	106
other	Abdominal Pain	Gastrointestinal disorders	All d-ATS Treatment During the Dose-Optimization Phase	7	110
other	Abdominal Pain	Gastrointestinal disorders	d-ATS Patch Treated Arm During the Double Blind Phase	3	106
other	Abdominal Pain	Gastrointestinal disorders	Placebo Treated Arm During the Double Blind Phase	1	106

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01711021/events?page=3

API reference For AI assistants

Adverse events60

Sources 3

Read this list from software.